Loading...
Not a good buy right now. SCI is sitting just above near-term support, but momentum is still bearish (negative/expanding MACD histogram) and the next-month pattern projection is negative (-5.03%). With no Intellectia buy signals today and put-heavy option volume implying caution/hedging into earnings, the risk/reward is not attractive for an impatient buyer at the current level (~79.64).
Price/levels: SCI is trading ~79.64, below the pivot (80.943) and just above S1 (79.102). A clean break below S1 raises downside risk toward S2 (77.965). Upside needs a reclaim of the pivot first, then resistance at R1 (82.785). Momentum: MACD histogram -0.239 and negatively expanding = bearish momentum still building. RSI: RSI_6 at 30.34 suggests the stock is near short-term oversold territory, but not yet showing a confirmed reversal signal. Moving averages: Converging MAs indicate consolidation/transition; combined with bearish MACD, it leans toward a weak-to-down bias. Stat/pattern outlook: Similar-pattern study shows 70% odds of small gains next day/week (+0.35% / +0.51%) but a notable expected decline over the next month (-5.03%), which argues against chasing now.
Intellectia Proprietary Trading Signals

Upcoming earnings event: Q4 2025 results on Feb 11, 2026 (after hours) with a follow-up call on Feb 12, 2026—potential catalyst if results/guide surprise positively.
Sector/defensive angle: Recent commentary frames SCI as a defensive, dividend-friendly name with a resilient business model, which can support demand during broader market weakness (S&P 500 down ~0.98% today).
Fundamental trend: Q3 2025 showed revenue growth (+4.35% YoY) and EPS growth (+2.47% YoY) with modest gross margin expansion.
if S1 (79.
fails.
indicates traders are actively hedging or positioning for downside into earnings.
Latest reported quarter: 2025/Q3. Revenue: $1.058B, +4.35% YoY (steady top-line growth). Net income: $117.5M, -0.30% YoY (essentially flat/slightly down—profit growth not keeping pace with revenue). EPS: $0.83, +2.47% YoY (modest per-share growth). Gross margin: 25.1%, +0.72% YoY (incremental margin improvement). Overall: Fundamentals look stable with mild growth, but not strong enough in the latest quarter to override the current bearish momentum/earnings-timing setup.
Analyst rating/price target trend: No analyst rating or price target change data was provided, so a recent trend assessment can’t be confirmed from the dataset. Wall Street-style pros vs cons (based on provided info): Pros: Defensive characteristics, dividend appeal, steady revenue/EPS growth, and an upcoming earnings catalyst. Cons: Near-term technical weakness, meaningful event risk ahead of earnings, and bearish near-term options volume flow suggesting caution.